Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2017-05-24 2017-05-16
Drug Identification Number 02245211 02245211
Brand name APO-LEVOCARB CR APO-LEVOCARB CR
Common or Proper name LEVOCARB LEVOCARB
Company Name AA PHARMA INC AA PHARMA INC
Ingredients CARBIDOPA LEVODOPA CARBIDOPA LEVODOPA
Strength(s) 50MG 200MG 50MG 200MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N04BA N04BA
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-15 2017-05-15
Estimated end date 2017-06-07 2017-06-02
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments